Anticoags, Antiplatelets, and Thrombolytics Flashcards
prevent the formation of clots that inhibit circulation
anticoagulants
prevent platelet aggregation, clumping together of platelets to form a clot
antiplatelets
called clot busters, attack and dissolve blood clots that have already formed
thrombolytics
combines with antithrombin III, which accelerates the anticoagulant cascade of reactions that prevents thrombosis formation. By inhibiting the action of thrombin, conversion of fibrinogen to fibrin does not occur, and the formation of a fibrin clot is prevented
heparin
lab tests for heparin
PTT and aPTT
control PTT: 60-70 sec (therapeutic 1.5-2x longer)
heparin can decrease platelet count
HIT
antidote for heparin
protamine sulfate
derivatives of standard heparin and the equivalent of anticoagulation can be achieved with a lower risk of bleeding
lab values do not need to be monitored
LMWH (dalteparin, enoxaparin)
half-life 2-4x longer than heparin
mostly used after hip and knee replacement
synthetically engineered antithrombotic designed to be effective as a once daily subq injection
selective Xa inhibitor
prevent DVT and PE after orthopedic/abdominal therapy
parenteral anticoagulants that directly inhibit thrombin from converting fibrinogen to fibrin
direct thrombin inhibitors: parenteral anticoagulants II
argatroban, dabigatran, -rudin
oral anticoag that inhibits hepatic synthesis of vitamin K, thus affecting clotting factors II, VII, IX, X
warfarin
prevent thromboembolic conditions
need regular lab draws
lab values to monitor on warfarin
PT and INR (2-3 therapeutic)
desired level of INR for pts with a mechanical heart valve
2.5-4.5 (book)
3-5 (lecture)
antidote for warfarin
vitamin K (24-48 hrs to be effective)
ACUTE BLEEDING: fresh frozen plasma
when smoking on warfarin you may need an ___ in dose
increase